ACE2 News and Research

RSS
COVAM assay may help select convalescent plasma units for treatment of  acute COVID-19

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

New method isolates antibody-like proteins that capture and neutralize SARS-CoV-2

New method isolates antibody-like proteins that capture and neutralize SARS-CoV-2

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2

Researchers develop non-infectious nanoparticle probes to study SARS-CoV-2

Researchers develop non-infectious nanoparticle probes to study SARS-CoV-2

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

Key China COVID-19 study produced results that influenced subsequent research on coronavirus

Key China COVID-19 study produced results that influenced subsequent research on coronavirus

Study invalidates Ebselen and other broad-spectrum SARS-CoV-2 Mpro inhibitors

Study invalidates Ebselen and other broad-spectrum SARS-CoV-2 Mpro inhibitors

Study sheds new light on the mechanism of COVID-19 infection

Study sheds new light on the mechanism of COVID-19 infection

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

Wearing eyeglasses protects against SARS-CoV-2

Wearing eyeglasses protects against SARS-CoV-2

Flexibility of glycosylated membrane-bound ACE2 suggests mechanical energy source in opening of SARS-CoV-2 spike

Flexibility of glycosylated membrane-bound ACE2 suggests mechanical energy source in opening of SARS-CoV-2 spike

Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus

Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

Conditions linked to obesity leave the lungs of obese patients more susceptible to COVID-19

Conditions linked to obesity leave the lungs of obese patients more susceptible to COVID-19

Candidate monoclonal antibody shows hope as COVID-19 treatment

Candidate monoclonal antibody shows hope as COVID-19 treatment

Heparan sulfate aids COVID-19 virus to penetrate human lung cells

Heparan sulfate aids COVID-19 virus to penetrate human lung cells

New images capture startlingly high SARS-CoV-2 viral loads

New images capture startlingly high SARS-CoV-2 viral loads